药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Papaverine
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Gallium nitrate.
Papaverine
Clostridium tetani toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Gallium nitrate.
Papaverine
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Gallium nitrate.
Papaverine
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Gallium nitrate.
Papaverine
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Gallium nitrate.
Papaverine
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Gallium nitrate.
Papaverine
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Gallium nitrate.
Papaverine
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Gallium nitrate.
Papaverine
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Gallium nitrate.
Papaverine
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Gallium nitrate.
Papaverine
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Gallium nitrate.
Papaverine
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Gallium nitrate.
Papaverine
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Gallium nitrate.
Papaverine
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Gallium nitrate.
Papaverine
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Gallium nitrate.
Papaverine
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Gallium nitrate.
Papaverine
Fingolimod
Gallium nitrate may increase the immunosuppressive activities of Fingolimod.
Papaverine
Tofacitinib
Gallium nitrate may increase the immunosuppressive activities of Tofacitinib.
Papaverine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gallium nitrate.
Papaverine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Gallium nitrate.